Prostate tuberculosis mimicking malignancy on 18F-FDG PET/CT in a patient with diffuse large B-cell lymphoma: A case report

被引:1
作者
Bai, Min [1 ]
Yu, Qinchuan [1 ]
Yuan, Ling [2 ]
Zhao, Yuanyuan [3 ]
Zheng, Meijing [1 ]
Su, Liping [1 ]
Wang, Lieyang [1 ]
机构
[1] Shanxi Med Univ, Shanxi Prov Canc Hosp, Shanxi Hosp Affiliated Canc Hosp, Shanxi Hosp,Canc Hosp,Dept Hematol, Taiyuan, Shanxi, Peoples R China
[2] Shanxi Med Univ, Shanxi Prov Canc Hosp, Shanxi Hosp Affiliated Canc Hosp, Shanxi Hosp,Canc Hosp,Dept PET CT, Taiyuan, Shanxi, Peoples R China
[3] Shanxi Med Univ, Shanxi Prov Canc Hosp, Shanxi Hosp Affiliated Canc Hosp, Shanxi Hosp,Canc Hosp,Dept Pathol, Taiyuan, Shanxi, Peoples R China
关键词
F-18-FDG; case report; lymphoma; PET/CT; tuberculosis;
D O I
10.1097/MD.0000000000038296
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Prostate tuberculosis (TB) is a rare and often underdiagnosed condition due to its nonspecific symptoms and imaging features, which can mimic malignancies on(18)F-fluorodeoxyglucose positron emission tomography (PET) scans. This resemblance poses a challenge in differentiating TB from prostate cancer, especially in patients with preexisting tumors such as diffuse large B-cell lymphoma. The purpose of this study is to highlight the importance of considering TB in the differential diagnosis of patients with atypical imaging findings, even in the presence of known malignancies. Case: We present a case of a 60-year-old man with diffuse large B-cell lymphoma who was initially misdiagnosed with a prostate tumor based on F-18-fluorodeoxyglucose PET/computed tomography scans. The subsequent ultrasound-guided prostate biopsy confirmed the presence of prostate TB, not malignancy. Conclusions: This case report underscores the critical role of considering TB as a potential diagnosis in patients with hematological tumors and atypical imaging results. It serves as a reminder for clinicians to exercise caution when interpreting PET/computed tomography scans and to incorporate TB into their differential diagnoses, thereby avoiding misdiagnosis and inappropriate treatment.
引用
收藏
页数:5
相关论文
共 4 条
[1]  
A Akdogan Remzi, 2018, Euroasian J Hepatogastroenterol, V8, P93, DOI 10.5005/jp-journals-10018-1270
[2]   The risk of tuberculosis in cancer patients is greatest in lymphoma and myelodysplastic syndrome/myeloproliferative neoplasm: a large population-based cohort study [J].
Ganzel, Chezi ;
Silverman, Barbara ;
Chemtob, Daniel ;
Ben Shoham, Assaf ;
Wiener-Well, Yonit .
LEUKEMIA & LYMPHOMA, 2019, 60 (03) :720-725
[3]   PET/CT imaging in management of concomitant Hodgkin lymphoma and tuberculosis - a problem solver tool [J].
Jehanno, Nina ;
Cassou-Mounat, Thibaut ;
Vincent-Salomon, Anne ;
Luporsi, Marie ;
Bedoui, Manel ;
Kuhnowski, Frederique .
CLINICAL CASE REPORTS, 2018, 6 (01) :232-234
[4]   Interim PET-driven strategy in de novo diffuse large B-cell lymphoma: do we trust the driver? [J].
Le Gouill, Steven ;
Casasnovas, Rene-Olivier .
BLOOD, 2017, 129 (23) :3059-3070